Literature DB >> 8434519

A reproducible model of reversible, focal, neocortical ischemia in Sprague-Dawley rat.

K Hiramatsu1, N F Kassell, Y Goto, S Soleau, K S Lee.   

Abstract

A reproducible model of reversible, focal ischemia was developed for use with the normotensive, Sprague-Dawley rat. Blood flow to the left cerebral hemisphere was interrupted by occluding simultaneously the left middle cerebral artery and both carotid arteries (CCA). The arterial occlusion lasted for 1, 2 or 3 hours after which animals survived for 3 days. The volume of brain infarction was determined utilizing computer-assisted measurements of serial brain sections stained with triphenyltetrazolium. Tissue infarctions of variable size were observed following arterial occlusions which persisted 1 or 2 hours. In contrast, remarkably-consistent infarction size was obtained following a three hours period of occlusion. Tissue edema was also estimated by measuring the volumes of the two hemispheres and expressing these values as a ratio for each animal. The volume ratio was significantly greater in the 3 hour ischemic group, indicating the occurrence of edema in the infarcted hemisphere. These results demonstrate that reversible vascular occlusion in the normal, Sprague-Dawley rat results in consistent amounts of tissue infarction. This approach represents an attractive model system for studying the pathophysiological effects of transient, focal ischemia and for testing the effects of putative, therapeutic strategies.

Entities:  

Mesh:

Year:  1993        PMID: 8434519     DOI: 10.1007/bf02001472

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  11 in total

1.  Arterial patterns of the rat rhinencephalon and related structures.

Authors:  P Coyle
Journal:  Exp Neurol       Date:  1975-12       Impact factor: 5.330

2.  Photothrombotic occlusion of rat middle cerebral artery: histopathological and hemodynamic sequelae of acute recanalization.

Authors:  H Nakayama; W D Dietrich; B D Watson; R Busto; M D Ginsberg
Journal:  J Cereb Blood Flow Metab       Date:  1988-06       Impact factor: 6.200

Review 3.  The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age.

Authors:  D Duverger; E T MacKenzie
Journal:  J Cereb Blood Flow Metab       Date:  1988-08       Impact factor: 6.200

4.  A new model of temporary focal neocortical ischemia in the rat.

Authors:  A M Buchan; D Xue; A Slivka
Journal:  Stroke       Date:  1992-02       Impact factor: 7.914

5.  Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion.

Authors:  P K Yip; Y Y He; C Y Hsu; N Garg; P Marangos; E L Hogan
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

6.  Middle cerebral artery occlusion in the young rat.

Authors:  P Coyle
Journal:  Stroke       Date:  1982 Nov-Dec       Impact factor: 7.914

7.  Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia.

Authors:  B Kaplan; S Brint; J Tanabe; M Jacewicz; X J Wang; W Pulsinelli
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

8.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

9.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.

Authors:  J B Bederson; L H Pitts; M Tsuji; M C Nishimura; R L Davis; H Bartkowski
Journal:  Stroke       Date:  1986 May-Jun       Impact factor: 7.914

10.  Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries.

Authors:  S Brint; M Jacewicz; M Kiessling; J Tanabe; W Pulsinelli
Journal:  J Cereb Blood Flow Metab       Date:  1988-08       Impact factor: 6.200

View more
  2 in total

1.  Trans-sodium crocetinate improves outcomes in rodent models of occlusive and hemorrhagic stroke.

Authors:  Yi Wang; Ryo Yoshimura; Hiroaki Manabe; Catherine Schretter; Ryon Clarke; Yu Cai; Mark Fitzgerald; Kevin S Lee
Journal:  Brain Res       Date:  2014-08-14       Impact factor: 3.252

2.  Protection against focal ischemic injury to the brain by trans-sodium crocetinate. Laboratory investigation.

Authors:  Hiroaki Manabe; David O Okonkwo; John L Gainer; Ryon H Clarke; Kevin S Lee
Journal:  J Neurosurg       Date:  2010-10       Impact factor: 5.115

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.